A complex of THAP1 with YY1 and HCFC1 has previously been shown to mediate activation at the SHLD promoter23, and the F81L dystonia mutation is thought to disrupt YY1 binding and hence impair THAP1-mediated transcriptional activation49. The gene discussed is YY1; the disease is Dystonia.